The European drugs regulator is holding firm with plans to review Covid-19 vaccines designed to tackle the original coronavirus and the Omicron variant, its head said, in contrast with US authorities who plan to approve these jabs before the release of clinical data on their efficacy.
欧洲药品监管机构负责人表示，该机构坚持审查旨在应对原始新冠病毒和奥密克戎变体的新冠疫苗的计划，而美国当局计划在公布有关疫苗疗效的临床数据之前批准这些疫苗。
您已阅读7%（362字），剩余93%（4670字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。